BMY-TPTX buyout_price_of $76.00 is_a 122% premium_to_yesterday’s_close. The nominal deal value is $4.1B. As a result of the acquisition, BMY is reducing 2022 non-GAAP EPS guidance by $0.08 plus a charge for in-process R&D to be determined later. (BMY’s prior 2022 non-GAAP EPS guidance was $7.44-7.74.) https://www.businesswire.com/news/home/20220603005198/en